AminoAnalytica
YC S24London, GB · Founded 2024 · 3 employees · 1 known investors
Amino Analytica designs rapid molecular diagnostic tests for emerging infectious diseases and biological threats, developed in weeks rather than the traditional 12+ months. The company combines point-of-care diagnostics technology with AI-driven bionanotechnology to enable earlier detection and faster pandemic response.
AI & Machine LearningBiotechHealthtechMedical DevicesNanosensorsSynthetic BiologyDiagnosticsUnited KingdomEuropePartly Remote
Founders & leadership· Y Combinator alumni (S24)
AminoAnalytica was founded in 2024 by Abhi Rajendran and Adam Wu.
Investors · 1
Competitors · 1
by search overlapCompanies competing with AminoAnalytica for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does AminoAnalytica do?
- Amino Analytica designs rapid molecular diagnostic tests for emerging infectious diseases and biological threats, developed in weeks rather than the traditional 12+ months. The company combines point-of-care diagnostics technology with AI-driven bionanotechnology to enable earlier detection and faster pandemic response.
- Who founded AminoAnalytica?
- AminoAnalytica was founded by Abhi Rajendran, Adam Wu in 2024.
- Who are AminoAnalytica's investors?
- AminoAnalytica's investors include Y Combinator.
- Where is AminoAnalytica headquartered?
- AminoAnalytica is headquartered in London, GB.